Amedisys Inc.
AMED
Market Cap$3.2B
Close$
$106.03
8.8% upside
Current Fair Value
8.8% upsideUndervalued by 8.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.20 Billion |
|---|---|
| Enterprise Value | $3.37 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $1.32 |
| Beta | 0.94 |
| Outstanding Shares | 32,793,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 27.94 |
|---|---|
| PEG | 8.63 |
| Price to Sales | 1.35 |
| Price to Book Ratio | 2.63 |
| Enterprise Value to Revenue | 1.42 |
| Enterprise Value to EBIT | 23.39 |
| Enterprise Value to Net Income | 27 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 0.38 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Amedisys Inc.
CEO: Paul Kusserow